The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Apatinib, a novel VEGFR inhibitor, combined with oral etoposide in patients with platinum-resistant or platinum-refractory ovarian cancer: A single-arm, open-label, phase 2 study.
 
Chunyan Lan
No Relationships to Disclose
 
Yin Wang
No Relationships to Disclose
 
Ying Xiong
No Relationships to Disclose
 
Judong Li
No Relationships to Disclose
 
Yanfang Li
No Relationships to Disclose
 
Yanna Zhang
No Relationships to Disclose
 
Min Zheng
No Relationships to Disclose
 
Yanling Feng
No Relationships to Disclose
 
Huiqiang Huang
No Relationships to Disclose
 
Xin Huang
No Relationships to Disclose